• Kiyoshi Fukunaga, Yasutsugu Takada, Masaaki Otsuka, Takeshi Todoroki, and Katashi Fukao.
• Department of Surgery, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan. kfukunaga@hkg.odn.ne.jp
• Hepato Gastroenterol. 2003 Nov 1; 50 (54): 1894-7.

Background/AimsHepatectomy is generally considered the only mode of curative treatment available for patients with colorectal liver metastases, even though recurrence occurs in more than 60% of the patients.MethodologyThis is a retrospective study examining the survival of 11 patients undergoing surgical excision of recurrences gained from 46 patients undergoing initial hepatectomy for metastatic colorectal cancer. These 46 patients had curative hepatectomy and no extrahepatic metastasis.ResultsCancer recurred in 29 of the 46 patients after a median follow-up time of 29.5 months (range 2-183 months), and 11 had curative resection of localized recurrences. In 6 patients, the liver was the only site of recurrence and 4 patients had isolated lung metastases. One patient had liver and lung metastases. There was no perioperative mortality. The median survival time and cumulative 5-year survival rate for 11 patients after the repeated resection were 28 months and 43.8%, respectively. These results were comparable to the survival for 46 patients after the initial hepatectomy, in which the median survival was 29.5 months and the 5-year survival rate was 49.0%.ConclusionsIn appropriately selected patients with colorectal cancer, surgical excision of localized recurrences after hepatectomy may be effective in prolonging survival.

36 keywords...

hide…